Collectively, we propose that one of the mechanisms driving chemoresistance in ovarian carcinoma with amplified BRD4 could be an increased DNA damage and generation of polyploid giant cells that arise as a result of BRD4-S overexpression. The gene discussed is BRD4; the disease is ovarian carcinoma.